Mechanisms and consequences of salt sensitivity and dietary salt intake

Current Opinion in Nephrology and Hypertension

Volumn 20, Issue 1, 2011, Pages 37-43

  Kanbay, Mehmet ^a   Chen, Yabing ^b,c,d   Solak, Yalcin ^e   Sanders, Paul W ^b,c,d  

^a FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^b Nephrology Research and Training Center ^*  (United States)

^c University of Alabama at Birmingham   (United States)

^d BIRMINGHAM VA MEDICAL CENTER   (United States)

^e SELCUK UNIVERSITY   (Turkey)

Author keywords

Arterial compliance; Dietary potassium; Dietary sodium; Nitric oxide; TGF

Indexed keywords

NITRIC OXIDE; POTASSIUM; SODIUM; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN C;

ARTICLE; BLOOD PRESSURE VARIABILITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; IMMUNOPATHOLOGY; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; NONHUMAN; POTASSIUM INTAKE; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALT INTAKE; SODIUM INTAKE; VASCULARIZATION;

ANIMALS; HUMANS; HYPERTENSION; IMMUNE SYSTEM; NITRIC OXIDE; POTASSIUM, DIETARY; SODIUM CHLORIDE, DIETARY; TRANSFORMING GROWTH FACTOR BETA;

EID: 79851513755     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32834122f1     Document Type: Article

References (48)

1. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25:305-313.
2. Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360:1347-1360. (Pubitemid 35341298)
3. Weinberger MH, Miller JZ, Luft FC, et al. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986; 8 (Suppl II):II-127 -II-134. (Pubitemid 16035851)
4. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 2001; 37 (2 Part 2):429-432. (Pubitemid 32199006)
5. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996; 27 (3 Pt 2):481-490. (Pubitemid 26084617)
6. Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362:590-599.
7. Machnik A, Neuhofer W, Jantsch J, et al. Macrophages regulate salt-depen-dent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism. Nat Med 2009; 15:545-552.
8. Ying W-Z, Sanders PW. Dietary salt enhances glomerular endothelial nitric oxide synthase through TGF-β1. Am J Physiol 1998; 275 (1 Pt 2):F18-F24.
9. Ying W-Z, Sanders PW. Dietary salt increases endothelial nitric oxide synthase and TGF-β1 in rat aortic endothelium. Am J Physiol 1999; 277 (4 Pt 2):H1293-H1298. (Pubitemid 29522657)
10. Elmarakby AA, Quigley JE, Imig JD, et al. TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2008; 294:R76-83.
11. Gu JW, Tian N, Shparago M, et al. Renal NF-kappaB activation and TNF-alpha upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 2006; 291:R1817-R1824. (Pubitemid 44904151)
12. Mazor R, Itzhaki O, Sela S, et al. Tumor necrosis factor-alpha: a possible priming agent for the polymorphonuclear leukocyte-reduced nicotinamide-adenine dinucleotide phosphate oxidase in hypertension. Hypertension 2010; 55:353-362.
13. Guzik TJ, Hoch NE, Brown KA, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007; 204:2449-2460. (Pubitemid 47529329)
14. Viel EC, Lemarie CA, Benkirane K, et al. Immune regulation and vascular inflammation in genetic hypertension. Am J Physiol Heart Circ Physiol 2010; 298:H938-H944.
15. Border WA, Okuda S, Languino LR, et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990; 346:371-374.
16. Derynck R, Jarrett JA, Chen EY, et al. Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316:701-705. (Pubitemid 16239342)
17. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003; 116 (Pt 2):217-224. (Pubitemid 36163863)
18. Zacchigna L, Vecchione C, Notte A, et al. Emilin1 links TGF-beta maturation to blood pressure homeostasis. Cell 2006; 124:929-942. (Pubitemid 43344234)
19. Dahly AJ, Hoagland KM, Flasch AK, et al. Antihypertensive effects of chronic anti-TGF-β antibody therapy in Dahl S rats. Am J Physiol Regul Integr Comp Physiol 2002; 283:R757-R767. (Pubitemid 34951629)
20. Ying W-Z, Sanders PW. Dietary salt modulates renal production of transforming growth factor-β in rats. Am J Physiol 1998; 274 (4 Pt 2):F635-F641.
21. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 1991; 88:1559-1567.
22. Chen PY, Sanders PW. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 1993; 22:812-818. (Pubitemid 23358087)
23. Deng X, Welch WJ, Wilcox CS. Renal vasoconstriction during inhibition of NO synthase: effects of dietary salt. Kidney Int 1994; 46:639-646. (Pubitemid 24272019)
24. Shultz PJ, Tolins JP. Adaptation to increased dietary salt intake in the rat: role of endogenous nitric oxide. J Clin Invest 1993; 91:642-650. (Pubitemid 23064150)
25. Bech JN, Nielsen CB, Ivarsen P, et al. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Am J Physiol 1998; 274 (5 Pt 2):F914-F923.
26. Ying W-Z, Sanders PW. The interrelationship between TGF-β1 and nitric oxide is altered in salt-sensitive hypertension. Am J Physiol Renal Physiol 2003; 285:F902-F908. (Pubitemid 37288636)
27. Ying WZ, Aaron K, Sanders PW. Dietary salt activates an endothelial prolinerich tyrosine kinase 2/c-Src/phosphatidylinositol 3-kinase complex to promote endothelial nitric oxide synthase phosphorylation. Hypertension 2008; 52:1134-1141.
28. Yu HCM, Burrell LM, Black MJ, et al. Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 1998; 98:2621-2628. (Pubitemid 29001204)
29. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46:200-204. (Pubitemid 40946514)
30. Todd AS, Macginley RJ, Scholium JB, et al. Dietary salt loading impairs arterial vascular reactivity. Am J Clin Nutr 2010; 91:557-564.
31. Gates PE, Tanaka H, Hiatt WR, Seals DR. Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension. Hypertension 2004; 44:35-41. (Pubitemid 38823484)
32. Dickinson KM, Keogh JB, Clifton PM. Effects of a low-salt diet on flow-mediated dilatation in humans. Am J Clin Nutr 2009; 89:485-490.
33. He FJ, Marciniak M, Visagie E, et al. Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension 2009; 54:482-488.
34. Oberleithner H, Riethmuller C, Schillers H, et al. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A 2007; 104:16281-16286. (Pubitemid 350099397)
35. Oberleithner H, Kusche-Vihrog K, Schillers H. Endothelial cells as vascular salt sensors. Kidney Int 2010; 77:490-494.
36. He FJ, Markandu ND, Sagnella GA, et al. Plasma sodium: ignored and underestimated. Hypertension 2005; 45:98-102. (Pubitemid 40066421)
37. Soucy KG, Ryoo S, Benjo A, et al. Impaired shear stress-induced nitric oxide production through decreased NOS phosphorylation contributes to agerelated vascular stiffness. J Appl Physiol 2006; 101:1751-1759. (Pubitemid 44904498)
38. Tolins JP, Shultz PJ. Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int 1994; 46:230-236. (Pubitemid 24210456)
39. Fujihara CK, Michellazzo SM, De Nucci G, Zatz R. Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. Am J Physiol 1994; 266 (5 Pt 2):F697-F705.
40. Ma S, Ma L, Yang D, et al. Uncoupling protein 2 ablation exacerbates high-salt intake-induced vascular dysfunction. Am J Hypertens 2010; 23:822-828.
41. Kopkan L, Hess A, Huskova Z, et al. High salt intake enhances superoxide activity in eNOS knockout mice leading to the development ofsalt-sensitivity. Am J Physiol Renal Physiol 2010; 299:F656-F663.
42. Intersalt: an International Study of Electrolyte Excretion and Blood Pressure. Results for 24 h urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 1988; 297:319-328.
43. Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997; 277: 1624-1632. (Pubitemid 27231195)
44. Cook NR, Obarzanek E, Cutler JA, et al. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med 2009; 169:32-40.
45. Berry SE, Mulla UZ, Chowienczyk PJ, Sanders TA. Increased potassium intake from fruit and vegetables or supplements does not lower blood pressure or improve vascular function in UK men and women with early hypertension: a randomised controlled trial. Br J Nutr 2010; 2:1-9.
46. He FJ, Marciniak M, Carney C, et al. Effects of potassium chloride and potassium bicarbonate on endothelial function, cardiovascular risk factors, and bone turnover in mild hypertensives. Hypertension 2010; 55:681-688.
47. Ying WZ, Aaron K, Wang PX, Sanders PW. Potassium inhibits dietary salt-induced transforming growth factor-beta production. Hypertension 2009; 54:1159-1163.
48. Oberleithner H, Callies C, Kusche-Vihrog K, et al. Potassium softens vascular endothelium and increases nitric oxide release. Proc Natl Acad Sci USA 2009; 106:2829-2834.